149 results
8-K
EX-10.1
ZSANQ
Zosano Pharma Corp
2 Jun 22
Termination of a Material Definitive Agreement
8:35am
10-Q
2022 Q1
EX-10.6
ZSANQ
Zosano Pharma Corp
Quarterly report
13 May 22
4:12pm
10-K
2021 FY
EX-10.42
ZSANQ
Zosano Pharma Corp
Annual report
17 Mar 22
4:09pm
10-K
2021 FY
EX-10.40
ZSANQ
Zosano Pharma Corp
Annual report
17 Mar 22
4:09pm
8-K
EX-10.1
u7kgyh
9 Feb 22
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-10.2
cctxs tu16q4m3e
9 Feb 22
Entry into a Material Definitive Agreement
5:21pm
8-K
EX-10.1
tvklspz67po7 vbogu
4 Oct 21
Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study Results
8:10am
8-K
EX-10.1
7bxo70
28 Jun 21
Entry into a Material Definitive Agreement
4:44pm
8-K
EX-10.2
iktmhks6u le8
6 Aug 20
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.1
ewres96cbirsu
6 Aug 20
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-10.1
esha9v44m mvv7m
8 Jun 20
Entry into a Material Definitive Agreement
5:19pm